← Top stories
● Neutral for Indian equities
Goyal-Greer meet: Can India still secure a tariff edge over rivals as Russia sanctions add uncertainty?
- India-US trade deal nearing broad understanding, tariff framework remains hurdle: Jaishankar
- Nifty Pharma defies market slump as select drugs get US tariff exemption
- US exempts selected Indian speciality drugs from 100% tariffs
- Goyal-Greer meet likely to focus on India-US BTA, interim trade deal: Commerce Ministry
- Goyal heads to US for G20 trade meeting and India-US deal talks